Skip to main content
KURA logo
KURA
(NASDAQ)
Kura Oncology, Inc.
$8.61-- (--)
Loading... - Market loading

Kura Oncology (KURA) Stock Price & Financial Analysis

Kura Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.15 - $8.94
52-Week High$12.49
52-Week Low$5.41
Open$8.15
Volume4.39M
Average Volume (3M)4.39M
Market Cap754.89M
Shares Outstanding87.68M
Price to Sales (P/S)10.84
Price to Book (P/B)4.20
EV/EBITDA-2.14
Revenue (TTM)67.48M
Net Income (TTM)-278.67M
Free Cash Flow (TTM)-70.70M
EPS (TTM)$-3.16
Profit Margin-412.95%
Operating Margin-449.94%
Return on Equity (ROE)-160.03%
Debt to Equity0.12
50-Day MA$8.41
200-Day MA$8.60
52-Week Change30.72%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Kura Oncology

What is the current stock price for KURA?

As of the latest trading session, KURA stock trades at $8.61. The 52-week range is $5.41–$12.49, with a day range of $8.15–$8.94.

What is the P/E ratio for KURA?

The P/E ratio (Price-to-Earnings) for KURA is shown in the Key Statistics section. This valuation metric helps compare Kura Oncology, Inc. to industry peers.

Does KURA pay dividends?

Kura Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KURA?

Based on 4 analysts, the consensus for KURA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KURA?

Kura Oncology's market capitalization is $754.9M, classifying it as a small-cap company. Kura Oncology operates in the Healthcare sector within the Biotechnology industry.